Cardinal Health 414, LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 5030 First Avenue South, Ste 110, Seattle, Washington (WA) 98134, United States (USA)
- Operations here
- manufacturepositron emission tomography drug production
- FDA identifiers
- FEI 3003706047 · DUNS 964768126
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-06-13
- VAIDrug Quality Assurance2020-02-25
- VAIDrug Quality Assurance2018-01-25
- VAIDrug Quality Assurance2015-11-03
- VAIDrug Quality Assurance2012-12-14
- VAIDrug Quality Assurance2009-04-17
Drugs this plant is listed as making
2 distinct drugs across 2 products name this site in their FDA label.
- Flurpiridaz F-18GE Healthcare Inc.
- Flutemetamol F-18GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare)
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.